PCRX insider filings

Pacira BioSciences, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen PCRX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 16 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
RIKER LAUREN — Senior Vice President, Finance2—1 leg · 6,000 sh · $217,92015
Brege Laura — Director1——12
CHRISTIE CHRISTOPHER — Director1——11
Froimson Mark — Director1——11
SLONIN JONATHAN — Chief Medical Officer1——7
WILLIAMS KRISTEN — Chief Administrative Officer1——7
BIGAL MARCELO — Director1——6
YANG MICHAEL J. — Director1——6
Young Alethia — Director1——5
Cross Shawn — Chief Financial Officer2——4

+4 more insiders in the window, not shown — every filing appears in the table below.

Recent insider filings — Pacira BioSciences, Inc.

FiledFormInsiderReported transactionsSource
2026-11-174SLONIN JONATHAN — Chief Medical OfficerDisposition to issuer (D): 216,729.67 @ $36.50 · Disposition to issuer (D): 35,500 (derivative) · Disposition to issuer (D): 14,137 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 24,800 (derivative) · Disposition to issuer (D): 27,500 (derivative) · +1 moreEDGAR
2026-11-174Brege Laura — DirectorCode (U): 23,715 @ $36.50 · Disposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 2,975 (derivative) · Disposition to issuer (D): 4,693 (derivative) · Disposition to issuer (D): 8,437 (derivative) · Disposition to issuer (D): 8,027 (derivative) · +6 moreEDGAR
2026-11-174RIKER LAUREN — Senior Vice President, FinanceCode (U): 6,881.24 @ $36.50 · Disposition to issuer (D): 55,403 @ $36.50 · Disposition to issuer (D): 6,250 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 6,000 (derivative) · +7 moreEDGAR
2026-11-174WIGGANS THOMAS G — DirectorDisposition to issuer (D): 32,675 (derivative)EDGAR
2026-11-174BIGAL MARCELO — DirectorCode (U): 11,393 @ $36.50 · Disposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 12,179 (derivative) · Disposition to issuer (D): 11,279 (derivative) · Disposition to issuer (D): 10,891 (derivative) · Disposition to issuer (D): 30,967 (derivative)EDGAR
2026-11-174Froimson Mark — DirectorCode (U): 20,136 @ $36.50 · Disposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 4,693 (derivative) · Disposition to issuer (D): 8,437 (derivative) · Disposition to issuer (D): 8,027 (derivative) · Disposition to issuer (D): 7,626 (derivative) · +5 moreEDGAR
2026-11-174Cross Shawn — Chief Financial OfficerCode (U): 9,210 @ $36.50 · Disposition to issuer (D): 86,591 @ $36.50 · Disposition to issuer (D): 150,000 (derivative)EDGAR
2026-11-174CHRISTIE CHRISTOPHER — DirectorCode (U): 16,654 @ $36.50 · Disposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 8,027 (derivative) · Disposition to issuer (D): 7,626 (derivative) · Disposition to issuer (D): 8,225 (derivative) · Disposition to issuer (D): 12,179 (derivative) · +5 moreEDGAR
2026-11-174Teehan Brendan — Chief Commercial OfficerDisposition to issuer (D): 100,934.27 @ $36.50 · Disposition to issuer (D): 99,500 (derivative)EDGAR
2026-11-174WILLIAMS KRISTEN — Chief Administrative OfficerDisposition to issuer (D): 167,062 @ $36.50 · Disposition to issuer (D): 2,953 (derivative) · Disposition to issuer (D): 10,560 (derivative) · Disposition to issuer (D): 19,685 (derivative) · Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 24,800 (derivative) · +1 moreEDGAR
2026-11-174YANG MICHAEL J. — DirectorCode (U): 13,393 @ $36.50 · Disposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 12,179 (derivative) · Disposition to issuer (D): 11,279 (derivative) · Disposition to issuer (D): 10,891 (derivative) · Disposition to issuer (D): 30,967 (derivative)EDGAR
2026-11-174Hirawat Samit — DirectorDisposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 10,891 (derivative) · Disposition to issuer (D): 39,291 (derivative)EDGAR
2026-11-174Young Alethia — DirectorDisposition to issuer (D): 17,798 @ $36.50 · Disposition to issuer (D): 12,179 (derivative) · Disposition to issuer (D): 11,279 (derivative) · Disposition to issuer (D): 10,891 (derivative) · Disposition to issuer (D): 30,967 (derivative)EDGAR
2026-11-174Lee Frank D. — Chief Executive Officer, DirectorDisposition to issuer (D): 660,830.84 @ $36.50 · Disposition to issuer (D): 692,512 (derivative)EDGAR
2026-11-034Cross Shawn — Chief Financial OfficerTax withholding (F): 9,540 @ $36.39EDGAR
2026-10-094RIKER LAUREN — Senior Vice President, FinanceOption exercise (M): 6,000 @ $32.35 · Sale (S): 6,000 @ $36.32 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2026-08-184SLONIN JONATHAN — Chief Medical OfficerSale (S): 3,040 @ $23.23EDGAR
2026-06-124Hirawat Samit — DirectorGrant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-06-124RIKER LAUREN — Senior Vice President, FinanceSale (S): 6,115 @ $23.50EDGAR
2026-06-124CHRISTIE CHRISTOPHER — DirectorGrant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-06-124Young Alethia — DirectorGrant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-06-124YANG MICHAEL J. — DirectorGrant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-06-124BIGAL MARCELO — DirectorGrant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-06-124Froimson Mark — DirectorGrant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-06-124Brege Laura — DirectorGrant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-06-124WIGGANS THOMAS G — DirectorGrant/award (A): 32,675 (derivative) @ $0EDGAR
2026-06-054RIKER LAUREN — Senior Vice President, FinanceTax withholding (F): 3,187 @ $22.32EDGAR
2026-06-054SLONIN JONATHAN — Chief Medical OfficerTax withholding (F): 4,728 @ $22.32EDGAR
2026-06-054WILLIAMS KRISTEN — Chief Administrative OfficerTax withholding (F): 8,528 @ $22.32 · Sale (S): 10,259 @ $22.27EDGAR
2026-04-244Cross Shawn — Chief Financial OfficerOption exercise (M): 12,941 @ $16.45 · Sale (S): 12,941 @ $25.16 · Option exercise (M): 12,941 (derivative) @ $0EDGAR
2026-04-224Cross Shawn — Chief Financial OfficerOption exercise (M): 7,714 @ $16.45 · Sale (S): 7,714 @ $25.14 · Option exercise (M): 2,845 @ $16.45 · Sale (S): 2,845 @ $25.01 · Option exercise (M): 1,500 @ $16.45 · Sale (S): 1,500 @ $25.01 · +3 moreEDGAR
2026-03-194SLONIN JONATHAN — Chief Medical OfficerSale (S): 3,261 @ $22.82EDGAR
2026-03-194Froimson Mark — DirectorSale (S): 500 @ $21.81EDGAR
2026-03-194/AKronenfeld Mark A. — DirectorGrant/award (A): 6,163 @ $0EDGAR
2026-02-134Cross Shawn — Chief Financial OfficerGrant/award (A): 49,091 @ $0EDGAR
2026-02-134Teehan Brendan — Chief Commercial OfficerGrant/award (A): 51,714 @ $0EDGAR
2026-02-134RIKER LAUREN — Senior Vice President, FinanceGrant/award (A): 19,273 @ $0EDGAR
2026-02-134SLONIN JONATHAN — Chief Medical OfficerGrant/award (A): 54,546 @ $0EDGAR
2026-02-134Lee Frank D. — Chief Executive Officer, DirectorGrant/award (A): 261,818 @ $0EDGAR
2026-02-134WILLIAMS KRISTEN — Chief Administrative OfficerGrant/award (A): 54,546 @ $0EDGAR
2026-02-034RIKER LAUREN — Senior Vice President, FinanceTax withholding (F): 2,751 @ $20.54 · Sale (S): 4,000 @ $20.81EDGAR
2026-02-034SLONIN JONATHAN — Chief Medical OfficerTax withholding (F): 6,168 @ $20.54EDGAR
2026-02-034Teehan Brendan — Chief Commercial OfficerTax withholding (F): 5,182 @ $20.54EDGAR
2026-02-034Lee Frank D. — Chief Executive Officer, DirectorTax withholding (F): 41,488 @ $20.54EDGAR
2026-02-034WILLIAMS KRISTEN — Chief Administrative OfficerTax withholding (F): 17,134 @ $20.54 · Sale (S): 13,137 @ $20.53EDGAR
2026-01-294Hirawat Samit — DirectorGrant/award (A): 39,291 (derivative) @ $0EDGAR
2026-01-064SLONIN JONATHAN — Chief Medical OfficerTax withholding (F): 381 @ $24.46EDGAR
2026-01-064RIKER LAUREN — Senior Vice President, FinanceTax withholding (F): 159 @ $24.46 · Sale (S): 1,416 @ $24.24EDGAR
2026-01-064Lee Frank D. — Chief Executive Officer, DirectorTax withholding (F): 9,272 @ $24.46EDGAR
2026-01-064Teehan Brendan — Chief Commercial OfficerGrant/award (A): 402.27 @ $10.76EDGAR

Recent 8-K events — Pacira BioSciences, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-178-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-128-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-058-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-088-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-308-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PCRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs